F.D.A. Approves a New Generic Abortion Pill

The decision enraged opponents of abortion, who have been pressuring the administration to restrict access to abortion medication.

News
How TrumpRx Website May Affect Your Drug Costs After Pfizer Deal

President Trump and top health officials announced a deal with Pfizer to try to lower Medicaid prices, and a website to help consumers buy drugs directly from manufacturers.

News
Philanthropies Strike a Promising Deal to Turn Back H.I.V.

Low- and middle-income countries will be able to purchase an effective preventative at a reduced price. The arrangements may help stem the epidemic 40 years after it began.

News
F.D.A.’s Approval of Drug for Autism Upends Review Process

The agency revived an old treatment for cancer patients, unilaterally approving it for a subset of people with autism. Experts worry that the narrower scope will get lost in the hype.

News
Where U.S. Medicines Are Made and How Trump’s Tariffs Could Affect Them

President Trump’s planned pharmaceutical tariffs threaten to hit many of the most common and well-known drugs that Americans take.

News
Aldi’s Passionate, Cultlike Following Fuels Its Rapid Expansion Plans

“It feels like I’m at a bougie store, but I’m not paying bougie prices,” one shopper said of the discount grocer, which is set to open hundreds of stores as consumers look to save and buy organic.

News
Oreo Maker Mondelez Sues Aldi Over Look-Alike Product Packaging

Mondelez International, a corporate giant behind the name-brand versions of many snacks, contends that Aldi is mimicking its packaging to dupe customers.

News
F.D.A. Scientists Are Reinstated at Agency Food Safety Labs

After 20 percent of the agency’s work force was cut, federal health officials have decided to bring back some experts and review firings to fill gaps in critical roles.

News
Trump’s Tariff Threat for Drug imports Poses Big Political Risks

Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of critical drugs.

News
Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs.

News